Dr. Nicola J. Mason's lab at the University of Pennsylvania focuses on developing advanced immunotherapy treatments for solid tumors using a unique type of immune cell called invariant natural killer T (iNKT) cells. These cells have the potential to effectively target and attack tumors while minimizing harmful side effects. The lab is particularly interested in creating and testing allogeneic CAR-engineered iNKTs in dogs with osteosarcoma, which is similar to a type of childhood cancer seen in humans. This research aims to enhance cancer treatment options and improve patient outcomes through innovative cell therapy approaches.

Dr. Stephen Joseph Galli's lab at Stanford University studies how genetic variations affect the immune responses of mast cells to honeybee venom. They aim to uncover how these immune responses can be both harmful, leading to allergic reactions, or beneficial, potentially offering protection against venom toxicity. Their research involves using genetically diverse mice to explore these pathways and identify ways to improve treatment for venom allergies and related disorders.

Dr. Hydar Ali's lab at the University of Pennsylvania focuses on studying mast cells, which are important immune cells involved in allergic reactions and inflammation. They are investigating how a newly discovered receptor, MRGPRX2, regulates mast cell responses in various diseases such as drug allergies, psoriasis, and rosacea. By understanding the signaling pathways and molecular interactions in mast cells, the lab aims to develop new treatments for these conditions.

Dr. Ryan McLaughlin's lab focuses on how maternal cannabis use during pregnancy affects the brain development and cognitive abilities of offspring. Using a unique animal model, the lab investigates the neurobiological mechanisms behind cognitive inflexibility caused by prenatal cannabis exposure. The research aims to understand the long-term impacts of cannabis on decision-making processes and explore potential interventions to mitigate these effects.

Dr. Guoqiang Gu's lab at Vanderbilt University focuses on understanding how maternal influences, particularly nutrition and obesity, affect the development and functioning of insulin-producing beta cells in offspring. They investigate the genetic and environmental factors that shape beta-cell populations, which are critical for maintaining healthy glucose levels and preventing diseases such as type 2 diabetes. The lab employs advanced genetic techniques to trace cellular lineages and analyze gene expression patterns in order to reveal relationships between maternal health, cellular identity, and diabetes risk in offspring.

Dr. Luciano Matzkin's lab at the University of Arizona explores the role of male ejaculate RNA in fertility and reproductive processes. The lab primarily studies how RNA transferred from males during mating affects female reproductive responses, leveraging innovative techniques to understand these complex interactions. This research has important implications for understanding fertility in various species, including humans, and could lead to new treatments for infertility.

Dr. Cameron McCarthy's lab focuses on understanding how diabetes affects the cerebrovascular system, particularly after a stroke. They study the role of a specific protein modification, known as O-GlcNAcylation, which may worsen neurovascular injuries and hinder recovery from stroke in diabetic patients. Their research aims to uncover mechanisms that could lead to new therapeutic targets for improving outcomes in stroke patients with diabetes.

Catherine D Mccusker's lab at the University of Massachusetts Boston studies how certain cells in axolotls, a type of salamander, can effectively regenerate limbs after injury. The lab focuses on the signaling pathways and epigenetic factors that allow these cells to respond to regenerative cues, aiming to uncover how to enhance regenerative abilities in mammals. Undergraduates in the lab gain hands-on experience with cutting-edge techniques to explore these fascinating biological processes.

Dr. Meghan E. McGee-Lawrence's lab focuses on understanding how HIV infection, aging, and antiretroviral therapy contribute to muscle and bone loss. The research aims to uncover the mechanisms behind these changes at the cellular level, particularly the role of the aryl hydrocarbon receptor (AhR). This knowledge could lead to improved treatments for older HIV patients suffering from related health issues.

Dr. Douglas McMahon's lab at Vanderbilt University focuses on how changes in natural light exposure affect brain circuits and behavior, particularly in relation to mood disorders. The research emphasizes the role of circadian rhythms and specific brain regions that are linked to anxiety and depression. By investigating these connections, the lab aims to understand the neurobiological mechanisms that govern mood regulation and motivation.

Dr. Yuan Chang's lab at the University of Pittsburgh focuses on understanding how the Merkel cell polyomavirus (MCPyV) persists in the human body and the mechanisms that can lead it to cause cancer. Their research delves into the virus's ability to control its replication and achieve a state of latency, which allows it to evade the immune system over long periods. By utilizing advanced techniques, they aim to unravel the intricate relationship between MCPyV and host cellular factors, shedding light on the development of targeted therapies for skin cancers caused by this virus.

Dr. Alan Keith Meeker's lab at Johns Hopkins University focuses on understanding prostate cancer treatment responses by investigating a telomere biomarker. This research aims to determine which patients might benefit from additional therapies after prostate surgery, helping to personalize and improve treatment decisions. By using advanced analysis of tumor biology, the lab seeks to identify patients who would either not benefit from aggressive treatments or who may need them to prevent disease progression.

Dr. Kathleen Janee Green's lab at Northwestern University focuses on understanding how skin cells, specifically melanocytes and keratinocytes, communicate and how this communication impacts the development of melanoma, a type of skin cancer. They explore how certain molecules, like desmoglein 1, change in response to environmental factors like UV radiation and how these changes contribute to cancer progression. This research has important implications in identifying early markers for melanoma and strategies for prevention.

Dr. A. Sue Menko's research lab at Thomas Jefferson University focuses on understanding how the immune system interacts with the eye, particularly in maintaining health after injuries like corneal wounds. The lab studies special immune cells associated with the lens of the eye to learn how they can either help restore balance or lead to problems such as cataracts and glaucoma. Their work is crucial for developing new treatments for eye diseases caused by inflammation.

Elena Ezhkova's lab investigates how Merkel cells, which are important for the sense of light touch, change in number and function as we age. They focus on uncovering the processes behind Merkel cell regeneration and their interaction with specific sensory neurons, especially in the context of dry skin and itch sensation. The goal is to understand these mechanisms to help develop treatments that could prevent age-related decline in Merkel cells and related skin sensitivities.

Jonathan Z Long's lab at Stanford University focuses on understanding how different types of metabolites, particularly ketone bodies and lactate, influence energy balance and metabolism in the body. They investigate specific biochemical pathways and how metabolic tissues communicate to maintain healthy function. The research aims to identify novel treatments for obesity and metabolic disorders by studying these metabolic signals and their interactions.

Dr. Yu-Jui Yvonne Wan's lab at UC Davis focuses on creating and testing a novel nanodrug aimed at improving metabolic health and preventing related cancers like liver and colorectal cancer. The lab studies how changes in gut bacteria affect the development of metabolic diseases and aims to design drugs that can effectively target these alterations. Their innovative approaches include developing compounds that can deliver specific biological signals to help combat conditions like insulin resistance and fatty liver disease.

Dr. Andrew Josef Ewald's lab at Johns Hopkins University studies how cancer cells change and behave as they spread from one part of the body to another. They use cutting-edge techniques, including single-cell sequencing and machine learning, to map these changes and understand the processes driving metastasis in breast cancer. The lab aims to identify potential new targets for treatments that could stop cancer from spreading and improve patient outcomes.

Dr. Eva Hernando's lab at NYU School of Medicine focuses on understanding the mechanisms behind cancer metastasis, particularly in melanoma and brain tumors. The lab investigates how certain proteins and epigenetic changes affect tumor spread and explores new therapeutic strategies to inhibit brain metastasis. Ultimately, the research aims to improve treatment options for patients with limited prospects.

Dr. Sui Huang's lab focuses on understanding and developing treatments for cancer metastasis, which is the spread of cancer to other parts of the body. They are working on identifying unique cellular structures associated with metastatic cancer to use as markers for drug testing. One promising drug, metarrestin, has shown effectiveness in preventing metastasis in laboratory settings and is now being tested in clinical trials for pancreatic cancer. The lab aims to create more effective treatments that target these specific cancer traits without harming normal cells.